Isogarcinol
(Synonyms: Cambogin) 目录号 : GC40901Isogarcinol是一种从藤黄属植物中提取的多异戊烯基取代的苯甲酮类天然化合物,Isogarcinol还是有效的乙酰胆碱酯酶(AChE;IC50=1.13μM)和丁酰胆碱酯酶(BChE;IC50=8.30μM)抑制剂。
Cas No.:71117-97-0
Sample solution is provided at 25 µL, 10mM.
Isogarcinol is a polyprenylated benzophenone natural compound extracted from plants of the Garciniagenus. Isogarcinol is also an effective inhibitor of acetylcholinesterase (AChE; IC₅₀=1.13μM) and butyrylcholinesterase (BChE; IC₅₀=8.30μM)[1-2]. Isogarcinol exhibits not only antileishmanial activity but also anticancer and immunomodulatory activities[3-4].
In vitro, breast cancer cell lines MDA-MB-231, MCF-7, T47D, and BT-549 were treated with Isogarcinol (1-17μM). Isogarcinol significantly inhibited cell viability, proliferation, invasion, and migration, while promoting apoptosis[5]. Human promyelocytic leukemia cells (HL-60 cells) were treated with Isogarcinol (5–20μg/mL) for 24–48 hours. Isogarcinol significantly inhibited cell proliferation and induced apoptosis, accompanied by G2/M phase cell cycle arrest[6].
In vivo, BALB/c mice were orally administered Isogarcinol (40–100mg/kg) daily for 6 days. Isogarcinol significantly suppressed 2,4-dinitrofluorobenzene (DNFB)-induced delayed-type hypersensitivity (DTH), alleviated ear swelling, and reduced the thymic index[7]. Chronic graft-versus-host disease (cGVHD) model BDF1 mice were orally administered Isogarcinol (30–60mg/kg) daily for 10 weeks. Isogarcinol significantly reduced proteinuria levels, improved renal histopathological damage, and corrected abnormal serum levels of blood urea nitrogen, creatinine, triglycerides, and cholesterol[8].
References:
[1] Schobert R, Biersack B. Chemical and Biological Aspects of Garcinol and Isogarcinol: Recent Developments. Chem Biodivers. 2019 Sep;16(9):e1900366.
[2] Lenta BN, Vonthron-Sénécheau C, Weniger B, et al. Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera. Molecules. 2007 Jul 20;12(8):1548-57.
[3] Chen S, Han K, Li H, et al. Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in Mice. J Agric Food Chem. 2017 Feb 1;65(4):846-857.
[4] Matsumoto K, Akao Y, Kobayashi E, et al. Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. Biol Pharm Bull. 2003 Apr;26(4):569-71.
[5] Zhang D, Chu Y, Li M, et al. Isogarcinol Reduces MARS Levels and Deactivates the PI3K/AKT Pathway to Suppress the Malignant Properties of Breast Cancer Cells. Cell Biochem Biophys. 2025 Sep;83(3):3437-3449.
[6] Pieme CA, Ambassa P, Yankep E, et al. Epigarcinol and isogarcinol isolated from the root of Garcinia ovalifolia induce apoptosis of human promyelocytic leukemia (HL-60 cells). BMC Res Notes. 2015 Nov 23;8:700.
[7] Cen J, Shi M, Yang Y, et al. Isogarcinol is a new immunosuppressant. PLoS One. 2013 Jun 13;8(6):e66503.
[8] Li W, Li H, Zhang M, et al. Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Systemic Lupus Erythematosus-like Disease in a Murine Model. J Agric Food Chem. 2015 Sep 30;63(38):8452-9.
Isogarcinol是一种从藤黄属植物中提取的多异戊烯基取代的苯甲酮类天然化合物,Isogarcinol还是有效的乙酰胆碱酯酶(AChE;IC50=1.13μM)和丁酰胆碱酯酶(BChE;IC50=8.30μM)抑制剂[1-2]。Isogarcinol不仅具有抑制利什曼原虫活性,还具有抑制癌症、调节免疫反应的活性[3-4]。
在体外,Isogarcinol (1-17μM) 处理乳腺癌细胞系 MDA-MB-231、MCF-7、T47D和BT-549。Isogarcinol显著抑制细胞的活力、增殖、侵袭和迁移能力,同时促进细胞凋亡[5]。Isogarcinol(5–20μg/mL)处理人早幼粒白血病细胞(HL-60细胞)24–48小时。Isogarcinol显著抑制细胞增殖并诱导细胞凋亡,同时引起G2/M期细胞周期阻滞[6]。
在体内,Isogarcinol(40–100mg/kg)每日口服给药BALB/c小鼠6天。Isogarcinol显著抑制2,4-二硝基氟苯(DNFB)诱导的迟发型超敏反应(DTH),减轻耳肿胀并降低胸腺指数[7]。Isogarcinol(30–60mg/kg)每日口服给药慢性移植物抗宿主病(cGVHD)模型BDF1小鼠10周。Isogarcinol显著降低蛋白尿水平并改善肾脏组织病理学损伤,同时纠正血清尿素氮、肌酐、甘油三酯和胆固醇的异常升高[8]。
| Cell experiment [1]: | |
Cell lines | MDA-MB-231, MCF-7, T47D, and BT-549 cells (human breast cancer cell lines) |
Preparation Method | Breast cancer (BC) cells were cultured in DMEM supplemented with 10% FBS and 1% antibiotics at 37°C, 5% CO₂. BC cells were treated with Isogarcinol at concentrations of 1, 5, 9, 13, and 17μM for 48 hours for viability assessment. |
Reaction Conditions | 1-17µM; 48h |
Applications | Isogarcinol (13μM) significantly reduced the viability, proliferation, colony formation, invasion, and migration capacities of breast cancer cells, while promoting cell apoptosis. Isogarcinol treatment also decreased the protein level of methionyl-tRNA synthetase (MARS) and deactivated the PI3K/AKT signaling pathway in BC cells. |
| Animal experiment [2]: | |
Animal models | BDF1 (C57BL/6 × DBA/2) mice with chronic graft-versus-host disease (cGVHD) |
Preparation Method | Mice were injected intravenously with 6 × 10⁷ DBA/2 spleen cells at day -7 and day 0 to induce cGVHD. Isogarcinol (30–60mg/kg; dissolved in 20% DMSO + 80% distilled water) was administered daily by oral gavage from day 1 until the end of the experiment. |
Dosage form | 30-60mg/kg; oral gavage; daily for 10 weeks. |
Applications | Isogarcinol (60mg/kg) significantly reduced proteinuria, improved renal histopathology, and corrected abnormal serum levels of blood urea nitrogen, creatinine, triglyceride, and cholesterol. Isogarcinol also decreased serum anti-dsDNA antibody and IgG1 concentrations, suppressed CD4⁺ T cell activation (reduced CD4/CD8 ratio and Th1/Th2 cytokine expression), and lowered inflammatory cytokine levels (TNF-α, IL-6, IL-1β) in kidneys and macrophages. |
References: | |
| Cas No. | 71117-97-0 | SDF | |
| 别名 | Cambogin | ||
| Canonical SMILES | CC([C@H](C/C=C(C)/C)C[C@]1(C[C@H](C/C=C(C)/C)C(C)(C)O2)C2=C3C(C4=CC(O)=C(O)C=C4)=O)(C)[C@](C/C=C(C)\C)(C1=O)C3=O | ||
| 分子式 | C38H50O6 | 分子量 | 602.8 |
| 溶解度 | DMF: 25 mg/ml,DMSO: 25 mg/ml,DMSO:PBS (pH 7.2) (1:10): 0.1 mg/ml,Ethanol: 20 mg/ml | 储存条件 | Store at -20°C, protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.6589 mL | 8.2946 mL | 16.5893 mL |
| 5 mM | 331.8 μL | 1.6589 mL | 3.3179 mL |
| 10 mM | 165.9 μL | 829.5 μL | 1.6589 mL |
| 第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
| 给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
| 第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
